Hematological Toxicity in Mice after High Activity Injections of <sup>177</sup>Lu-PSMA-617

Prostate cancer (PC) is one of the most common malignancies affecting men, with poor prognosis after progression to metastatic castration-resistant prostate cancer (mCRPC). Radioligand therapy (RLT) targeting the overexpressed PSMA on PC cells, with, e.g., <sup>177</sup>Lu-PSMA-617, has...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Main Authors: Amanda Kristiansson, Oskar Vilhelmsson Timmermand, Mohamed Altai, Joanna Strand, Sven-Erik Strand, Bo Åkerström, Anders Örbom
Formáid: Artigo
Teanga:Inglês
Foilsithe: MDPI AG 2022-03-01
Sraith:Pharmaceutics
Ábhair:
radioligand therapy
<sup>177</sup>Lu-PSMA-617
prostate cancer
mouse model
hematotoxicity
Rochtain Ar Líne:https://www.mdpi.com/1999-4923/14/4/731
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla